<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="2c68ccc9-dfff-41a9-ae4d-9d08ea1b4042"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Gynecologic Oncology Consultation — Ada Lovelace</title>
  <effectiveTime value="20260616120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="df659867-7623-4252-b55d-fdf604e618ca"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="190fed41-b08c-4c17-9cd7-7c440147c15f" extension="HR-NI031-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-31-6729"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ada</given><family>Lovelace</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19901210"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260616120000-0500"/>
    <assignedAuthor><id root="9e399f6f-4178-4d50-991e-5aae07fc1a24"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatrix</given><family>Lindgren-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260616120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="9e399f6f-4178-4d50-991e-5aae07fc1a24"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatrix</given><family>Lindgren-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="347e7af0-7a2c-41ba-ae8f-f8ef1f29487b"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="9e399f6f-4178-4d50-991e-5aae07fc1a24"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatrix</given><family>Lindgren-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="99965dd9-cfb8-4230-a2ac-4c2f3c2ccf67"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week follow-up and gynecologic oncology consultation: pathology, MRI and PET-CT, staging, treatment intent, palliative care, and long-acting morphine</originalText></code>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="9e399f6f-4178-4d50-991e-5aae07fc1a24"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Beatrix</given><family>Lindgren-Osei</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Friable exophytic cervical mass with five months of abnormal bleeding and constant pelvic pain in a 35-year-old woman, biopsied today, with iron deficiency anemia. Please confirm the diagnosis, stage the disease, advise on treatment intent and options, and help with control of bleeding and pain. [S]</paragraph><paragraph>Urgency: Within two weeks; pathology expected within a week. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>What is the diagnosis, and what further staging is needed?</item><item>Is the intent of treatment curative or palliative, and what treatment do you recommend?</item><item>How should the bleeding be controlled?</item><item>Which tumor or genetic tests are needed?</item><item>How should her pain and long-term opioid therapy be managed during treatment?</item><item>When should palliative care be involved?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mrs. Lovelace, a 35-year-old mathematician, is seen at the request of Dr. Whitley-Adeyemi for a cervical mass found two weeks ago after five months of abnormal bleeding and pelvic pain. The bleeding is lighter since the first iron infusion but continues. Her pain averages 6 of 10 on oral morphine solution 5 mg about six times a day, without drowsiness; she stopped the opium tincture she had taken for two years. She has no cough, hemoptysis, bone pain, leg swelling, or urinary or bowel symptoms beyond opioid-related constipation. She has never had cervical screening. She does not wish to preserve fertility. She asked to be told the findings directly. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Augusta Ada Byron was born on December 10, 1815, in Piccadilly, London, the daughter of the poet Lord Byron and Anne Isabella Byron. [D]</item><item>She was often ill as a child. In 1829, at 13, she caught measles, from which she took a long while to recover; she was bedridden for a whole year. [D]</item><item>On July 8, 1835, she married William King, who was created an earl in 1838, making her Countess of Lovelace. [D]</item><item>Her health suffered after a bout of cholera in 1837, and she had lingering problems with asthma and her digestive system. [D]</item><item>Her doctors gave her painkillers such as laudanum and opium; she reportedly had mood swings and hallucinations. [D]</item><item>Between 1842 and 1843 she translated L. F. Menabrea&apos;s article on Charles Babbage&apos;s Analytical Engine and added her own extensive Notes, published in 1843 under the initials A.A.L. The Notes, which include a method for computing Bernoulli numbers on the engine, are often described as the first published computer program. [D]</item><item>Her health, always fragile, declined sharply after 1843. By the end of that year she was taking several medicines for different health problems; in 1844 she wrote that a recent illness had left her &apos;utterly unable to think even of my studies&apos;, and she thought of writing a scientific study of the effects of opium and wine based on her own experience. In the 1840s she had what she called heart or rheumatic attacks. [D]</item><item>Gambling on horses was a passion of her later years, and she pawned some of her jewels to finance it. [D]</item><item>By 1851 she was extremely sick with uterine cancer. [D]</item></list><paragraph>3 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="fe746d88-fa88-4408-b6d4-4a6ff5cf073c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260602"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="cbccaded-b290-4d00-a20d-bbd3ee9143fd"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain</td><td>0.5 mL four to six times a day as needed</td><td>Oral route</td><td>2024-06-03 to 2026-06-02</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain</td><td>5 mg every 4 hours as needed</td><td>Oral route</td><td>2026-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-3"><td>Morphine sulfate extended-release 15 mg tablet, one tablet by mouth every 12 hours; swallow whole</td><td>every 12 hours</td><td>Oral route</td><td>2026-06-16 to 2026-10-20</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911</td><td>one spray as needed for suspected overdose; repeat after 2 to 3 minutes if needed</td><td>Nasal route</td><td>2026-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-6"><td>Senna 8.6 mg tablet, two tablets by mouth at night</td><td>two tablets at night</td><td>Oral route</td><td>2026-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Polyethylene glycol 3350, 17 g in water by mouth once or twice a day</td><td>once daily, up to twice daily</td><td>Oral route</td><td>2026-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Acetaminophen 500 mg tablet, two tablets by mouth three times a day</td><td>1 g three times a day</td><td>Oral route</td><td>2026-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-9"><td>Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits</td><td>750 mg on two occasions two weeks apart</td><td>Intravenous route</td><td>2026-06-02 to 2026-06-17</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="2e083f02-22ed-4367-a207-e6a4cea3e69a"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20240603"/><high value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="4" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="0.5" unit="mL"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="830196" codeSystem="2.16.840.1.113883.6.88" displayName="opium tincture 100 MG/ML Oral Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ccec55f9-348d-4c64-a1a1-64b9c563f9a8"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="4332c8ef-7343-4a89-b310-7fdddbaf8ffa"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="4" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="5" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="892589" codeSystem="2.16.840.1.113883.6.88" displayName="morphine sulfate 2 MG/ML Oral Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="cfb6e875-03c9-4707-825f-fc0e660aea0c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N93.8" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified abnormal uterine and vaginal bleeding"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f7bd2efe-5657-4532-b10c-fed2fdf6c419"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="d42553bb-ba75-40fc-a29f-277f1a2a48eb"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260616"/><high value="20261020"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="15" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="891881" codeSystem="2.16.840.1.113883.6.88" displayName="morphine sulfate 15 MG Extended Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a99acb20-886f-4a6b-b49d-0a37cba1e45d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G89.3" codeSystem="2.16.840.1.113883.6.90" displayName="Neoplasm related pain (acute) (chronic)"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="375c2cb5-d983-4a62-9d18-edf6d1bcf855"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38284" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Nasal route"/>
      <doseQuantity value="4" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1725059" codeSystem="2.16.840.1.113883.6.88" displayName="naloxone hydrochloride 40 MG/ML Nasal Spray"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="73834b26-e88e-40c2-bd4e-ca8756e1d0e6"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c9f7ff14-9974-45cc-9c02-d5a9c7aee9e2"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="17.2" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="312935" codeSystem="2.16.840.1.113883.6.88" displayName="sennosides, USP 8.6 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6fa54bb8-8c3c-4699-be03-1334fff670a4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="20f766a9-80a2-4e5c-8dd7-a024f415b3a8"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="17" unit="g"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="876193" codeSystem="2.16.840.1.113883.6.88" displayName="polyethylene glycol 3350 17000 MG Powder for Oral Solution"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4764afc4-c580-4dd4-9b20-7c96b626a2fc"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b0d5a0b1-da15-45c4-a6e7-9ce1880180a2"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="8" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="80c4841d-51a1-4aef-be36-6e87d9b8794e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N93.8" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified abnormal uterine and vaginal bleeding"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="0e51a3cb-7886-4d95-a62d-6427c613a311"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G89.3" codeSystem="2.16.840.1.113883.6.90" displayName="Neoplasm related pain (acute) (chronic)"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="263f4cf2-0c59-4801-a831-d3971de88b0a"/>
      <text><reference value="#medication-9"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260602"/><high value="20260617"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="14" unit="d"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="750" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1435169" codeSystem="2.16.840.1.113883.6.88" displayName="15 ML ferric carboxymaltose 50 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="483a25a9-fdbc-4193-ac74-4465d5eedb5c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="D50.0" codeSystem="2.16.840.1.113883.6.90" displayName="Iron deficiency anemia secondary to blood loss (chronic)"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intake</td><td>resolved</td><td>confirmed</td>
    <td>N93.8</td><td>S — Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairs</td><td>active</td><td>confirmed</td>
    <td>D50.0</td><td>S — Synthetic modern finding anchored to her documented final illness.</td>
  </tr>
  <tr ID="problem-3">
    <td>Adenocarcinoma of the endocervix, usual (HPV-associated) type, HPV 18 positive, FIGO 2018 stage IVB: a 5.2 cm tumor with left parametrial invasion, metastases to left pelvic and para-aortic lymph nodes, and bilateral lung metastases on MRI and PET-CT; PD-L1 combined positive score 5, mismatch repair proficient, HER2 1+; treated with palliative pelvic radiation for bleeding and carboplatin, paclitaxel and pembrolizumab, with specialist palliative care from diagnosis</td><td>active</td><td>confirmed</td>
    <td>C53.0</td><td>S — Synthetic modern diagnosis made at the second visit, anchored to her documented uterine cancer; the cervical site is a synthetic choice.</td>
  </tr>
  <tr ID="problem-4">
    <td>Cancer-related pelvic pain, nociceptive and visceral, from the cervical tumor and its left parametrial extension</td><td>active</td><td>confirmed</td>
    <td>G89.3</td><td>S — Synthetic modern diagnosis made at the second visit.</td>
  </tr>
  <tr ID="problem-5">
    <td>Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone supplied</td><td>active</td><td>confirmed</td>
    <td>Z79.891</td><td>S — Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="e87d2b0e-f0c4-43a5-bf68-2ad7d25eee60"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260602"/><high value="20260616"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="278dfb44-ee8d-48db-9671-4883a2b2d6ab"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260602"/><high value="20260616"/></effectiveTime>
          <value xsi:type="CD" code="N93.8" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified abnormal uterine and vaginal bleeding"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="ddabdc25-a2bd-401e-9783-f42ffca6894b"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260602"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="5a15ab91-33a3-4a4f-9351-5b55568777bb"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260602"/></effectiveTime>
          <value xsi:type="CD" code="D50.0" codeSystem="2.16.840.1.113883.6.90" displayName="Iron deficiency anemia secondary to blood loss (chronic)"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="39745ec7-9366-4575-be90-a5a13a4edc2e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260616"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="a5dfb318-4ba0-46b2-bff2-738d853aa477"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260616"/></effectiveTime>
          <value xsi:type="CD" code="C53.0" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of endocervix"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="38b5a559-10f9-44a5-879a-663da69f9325"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260616"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9d334e64-9351-48e4-b487-a9fcd7db5f7b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260616"/></effectiveTime>
          <value xsi:type="CD" code="G89.3" codeSystem="2.16.840.1.113883.6.90" displayName="Neoplasm related pain (acute) (chronic)"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="563a127b-b1a4-4276-86cb-6278095d77cc"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260602"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c3105918-ff5e-4348-b07e-613d426e49cf"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260602"/></effectiveTime>
          <value xsi:type="CD" code="Z79.891" codeSystem="2.16.840.1.113883.6.90" displayName="Long term (current) use of opiate analgesic"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-06-16; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Pale, alert, not sedated; blood pressure 106/66, pulse 92; ECOG performance status 1</td></tr><tr><td>Lymph nodes</td><td>No supraclavicular or inguinal lymph node enlargement</td></tr><tr><td>Abdomen</td><td>Soft; mild suprapubic tenderness; no masses</td></tr><tr><td>Pelvis</td><td>Exophytic friable cervical tumor about 5 cm with light bleeding; left parametrial thickening not reaching the sidewall; vagina free; rectovaginal septum free</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-13"><td>2026-06-16</td><td>Hemoglobin [Mass/volume] in Blood</td><td>9</td><td>g/dL</td><td>12-15.5 g/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-14"><td>2026-06-16</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.66</td><td>mg/dL</td><td>0.57-1 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-15"><td>2026-06-16</td><td>Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma</td><td>17</td><td>U/L</td><td>7-35 U/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-16"><td>2026-06-16</td><td>Thyrotropin [Units/volume] in Serum or Plasma</td><td>1.9</td><td>m[IU]/L</td><td>0.45-4.5 mIU/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-17"><td>2026-06-16</td><td>Thyroxine (T4) free [Mass/volume] in Serum or Plasma</td><td>1.2</td><td>ng/dL</td><td>0.8-1.8 ng/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-18"><td>2026-06-16</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>117</td><td>mL/min/{1.73_m2}</td><td>60 or more</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-19"><td>2026-06-16</td><td>Pain severity - 0-10 verbal numeric rating [Score] - Reported</td><td>6</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="7a8b72f9-647f-4eaa-b8a5-647c44ddea10"/>
      <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="1c6ed083-decd-4da0-a57a-71bd09dae9b6"/>
          <code code="718-7" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin [Mass/volume] in Blood"/>
          <text><reference value="#result-13"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="9" unit="g/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>12-15.5 g/dL</text>
              <value xsi:type="IVL_PQ"><low value="12" unit="g/dL"/><high value="15.5" unit="g/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="76f1d5ce-9d51-49b2-897a-8088b373bdd1"/>
      <code code="51990-0" codeSystem="2.16.840.1.113883.6.1" displayName="Basic metabolic panel - Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="e99850c2-a411-4315-b4eb-f3702d9922ad"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-14"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="0.66" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.57-1 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.57" unit="mg/dL"/><high value="1" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="beab35cc-03d9-41ad-b5bc-b48f64204f50"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-18"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="117" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>60 or more</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6216caf1-f786-4f96-890a-9bb91edb757a"/>
      <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="2a0bd122-0468-41d2-8a63-82302e1cd3a7"/>
          <code code="1742-6" codeSystem="2.16.840.1.113883.6.1" displayName="Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma"/>
          <text><reference value="#result-15"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="17" unit="U/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>7-35 U/L</text>
              <value xsi:type="IVL_PQ"><low value="7" unit="U/L"/><high value="35" unit="U/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="b633f3fc-bc4b-41b5-81d8-6db7caf3948e"/>
      <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="6faa7a79-486c-419a-86b3-108b1d1135e8"/>
          <code code="3016-3" codeSystem="2.16.840.1.113883.6.1" displayName="Thyrotropin [Units/volume] in Serum or Plasma"/>
          <text><reference value="#result-16"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="1.9" unit="m[IU]/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.45-4.5 mIU/L</text>
              <value xsi:type="IVL_PQ"><low value="0.45" unit="m[IU]/L"/><high value="4.5" unit="m[IU]/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="aae1a04b-bb32-4de0-b209-a532bd70739f"/>
      <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="984b6722-ac7a-44e7-a01f-abe54ef9334d"/>
          <code code="3024-7" codeSystem="2.16.840.1.113883.6.1" displayName="Thyroxine (T4) free [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-17"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="1.2" unit="ng/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.8-1.8 ng/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.8" unit="ng/dL"/><high value="1.8" unit="ng/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="ded808e5-b1a2-4b07-bff5-ce0883f49c3b"/>
      <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260616"/><high value="20260616"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="d0c9035e-3787-41ff-924a-3f956559c864"/>
          <code code="72514-3" codeSystem="2.16.840.1.113883.6.1" displayName="Pain severity - 0-10 verbal numeric rating [Score] - Reported"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260616"/>
          <value xsi:type="PQ" value="6" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Adenocarcinoma of the cervix, HPV 18 positive, FIGO 2018 stage IVB by imaging (C53.0). The lung nodules and para-aortic nodes on PET-CT mean distant spread, stage IVB by imaging; because this decides that treatment is palliative rather than curative, a lung nodule should be biopsied to confirm it before systemic therapy. With PD-L1 combined positive score 5, the NCCN preferred first-line treatment is carboplatin or cisplatin with paclitaxel and pembrolizumab, with or without bevacizumab, based on KEYNOTE-826. I recommend carboplatin, for ease and less toxicity, and leaving out bevacizumab for now, because she is bleeding from the tumor and will have pelvic radiation, which raise the risks of hemorrhage and fistula. Cervical cancer is not part of a hereditary cancer syndrome, so germline testing is not indicated; the tumor biomarkers are complete for first-line and later choices. [S]</item><item>Iron deficiency anemia from tumor bleeding (D50.0). Bleeding will not stop without treating the tumor. A short course of palliative pelvic radiation controls bleeding in most patients within one to two weeks. Transfusion if hemoglobin falls below 7 to 8 g/dL or she has symptoms. [S]</item><item>Cancer-related pelvic pain (G89.3). Constant visceral and nociceptive pain from the tumor and parametrial spread, needing scheduled opioid therapy, which radiation and systemic treatment should also reduce. Her long prior use of opium tincture does not argue against opioids for cancer pain, but calls for clear, measured dosing, one prescriber, and attention to sedation, given her wish for a clear mind. [S]</item></list><paragraph>Data reviewed: Cervical biopsy: invasive adenocarcinoma, usual (HPV-associated) type, p16 diffusely positive, HPV 18 detected; PD-L1 combined positive score 5; mismatch repair proteins retained; HER2 immunohistochemistry 1+. Pelvic MRI a week ago: 5.2 cm endocervical tumor with left parametrial invasion, not reaching the sidewall, no hydronephrosis, an enlarged left external iliac node. FDG PET-CT five days ago: avid tumor, avid left pelvic and para-aortic nodes, six avid nodules in both lungs up to 1.4 cm, no bone or liver lesions. Hemoglobin 9.0 g/dL today, from 8.4; creatinine 0.66 mg/dL; ALT 17 U/L; TSH 1.9 mIU/L; HIV, hepatitis B and hepatitis C tests negative. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>CT-guided biopsy of a lung nodule to confirm metastatic disease. [S]</item><item>Palliative pelvic radiation, 20 Gy in 5 fractions, starting next week, for bleeding and pain. [S]</item><item>Then carboplatin (AUC 5), paclitaxel 175 mg/m2 and pembrolizumab 200 mg every 3 weeks for six cycles, with pembrolizumab continuing as maintenance; no bevacizumab for now. [S]</item><item>Blood counts, creatinine and ALT before each cycle; TSH and free T4 at baseline and every six weeks on pembrolizumab; restaging CT after four cycles. [S]</item><item>No germline genetic testing. [S]</item><item>Long-acting morphine 15 mg every 12 hours with morphine solution 5 mg as needed for breakthrough pain, a daily bowel regimen, naloxone, and one prescriber, under Dr. Whitley-Adeyemi with the palliative care team. [S]</item><item>Specialist palliative care alongside treatment from today. [S]</item><item>Complete intravenous iron; transfuse only below 7 to 8 g/dL or for symptoms. [S]</item><item>Dr. Whitley-Adeyemi and I gave Mrs. Lovelace the diagnosis together, at her request, in plain words: the cancer has spread and cannot be cured, and treatment aims to stop the bleeding, ease the pain, control the cancer and help her live longer and well. She asked about treatment and its effects on her thinking, and chose radiation and chemotherapy with pembrolizumab. The palliative care team saw her the same afternoon. [S]</item><item>Follow-up: Gynecologic oncology after the lung biopsy and before the first cycle, then before each cycle, with restaging after four cycles. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
